Search
forResearch 10 of 877
- Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- Abstract 5219: The role of MEK and Antizyme in keratinocyte stem cell expansion and differentiation
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →